QSAR modeling of dihydrofolate reductase inhibitors as a therapeutic target for multiresistant bacteria

Structural Chemistry

Volumn 29, Issue 2, 2018, Pages 541-551

  Veselinović, Jovana B ^a   Đorđević, Vukica ^a   Bogdanović, Milena ^a   Morić, Ivana ^b   Veselinović, Aleksandar M ^a  

^a UNIVERSITY OF NI   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

CORAL software; Dihydrofolate reductase inhibitions; Pyramidine derivatives; QSAR; SMILES

Indexed keywords

EID: 85033466391     PISSN: 10400400     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11224-017-1051-7     Document Type: Article

References (34)

1. Selassie CD, Li RL, Poe M, Hansch C (1991) On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase. J Med Chem 34:46–54
2. Schweitzer BI, Dicker AP, Bertino JR (1990) Dihydrofolate reductase as a therapeutic target. FASEB J 4:2441–2452
3. Li R, Sirawaraporn R, Chitnumsub P, Sirawaraporn W, Wooden J, Athappilly F, Turley S, Hol WG (2000) Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs. J Mol Biol 295:307–323
4. Sirawaraporn W, Sertsrivanich R, Booth RG, Hansch C, Neal RA, Santi DV (1988) Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines. Mol Biochem Parasitol 31:79–85
5. Gangjee A, Kurup S, Namjoshi O (2007) Dihydrofolate reductase as a target for chemotherapy in parasites. Curr Pharm Des 13:609–639
6. Hitchings GH, Burchall JJ (1965) Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol Relat Areas Mol Biol 27:417–468
7. Sign P, Kaur M, Sachdeva S (2012) Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents. J Med Chem 55:6381–6390
8. Then RL (2004) Antimicrobial dihydrofolate reductase inhibitors—achievements and future options: review. J Chemother 16:3–12
9. Blaney JM, Hansch C, Silipo C, Vittoria A (1984) Structure-activity relationships of dihydrofolate reductase inhibitors. Chem Rev 84:333–407
10. Ivanciuc O, Ivanciuc T, Cabrol-Bass D (2002) QSAR for dihydrofolate reductase inhibitors with molecular graph structural descriptors. J Mol Struc-Theochem 582:39–51
11. Hawser S, Lociuro S, Islam K (2006) Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol 71:941–948
12. Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M, Dearden J, Gramatica P, Martin YC, Todeschini R, Consonni V, Kuz’Min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, Gasteiger J, Richard A, Tropsha A (2014) QSAR modeling: where have you been? Where are you going to? J Med Chem 57:4977–5010
13. Hansch C, Hoekman D, Gao H (1996) Comparative QSAR: toward a deeper understanding of chemicobiological interactions. Chem Rev 96:1045–1076
14. Tropsha A, Golbraikh A (2007) Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Curr Pharm Des 13:3494–3504
15. Duchowicz PR, Comelli NC, Ortiz EV, Castro EA (2012) QSAR study for carcinogenicity in a large set of organic compounds. Curr Drug Saf 7:282–288
16. Talevi A, Bellera CL, Ianni MD, Duchowicz PR, Bruno-Blanch LE, Castro EA (2012) An integrated drug development approach applying topological descriptors. Curr Comput Aided Drug Des 8:172–181
17. Katritzky AR, Gordeeva EV (1993) Traditional topological indices vs electronic, geometrical and combined molecular descriptors in QSAR/QSPR research. J Chem Inf Comp Sci 33:835–857
18. González-Díaz H, Vilar S, Santana L, Uriarte E (2007) Medicinal chemistry and bioinformatics—current trends in drugs discovery with networks topological indices. Curr Top Med Chem 7:1015–1029
19. Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28:31–36
20. Weininger D, Weininger A, Weininger JL (1989) SMILES. 2. Algorithm for generation of unique SMILES notation. J Chem Inf Comput Sci 29:97–101
21. Weininger D (1990) SMILES. 3. Depict. Graphical depiction of chemical structures. J Chem Inf Comput Sci 30:237–243
22. Veselinović AM, Veselinović JB, Živković JV, Nikolić GM (2015) Application of SMILES notation based optimal descriptors in drug discovery and design. Curr Top Med Chem 15:1768–1779
23. Toropov AA, Toropova AP, Benfenati E, Nicolotti O, Carotti A, Nesmerak K, Veselinovic AM, Veselinovic JB, Duchowicz PR, Bacelo DE, Castro EA, Rasulev BF, Leszczynska D, Leszczynski J (2015) In Roy K (ed) Quantitative structure-activity relationships in drug design, predictive toxicology, and risk assessment. IGI Global
24. Ojha PK, Roy K (2011) Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chemom Intell Lab Sys 109:146–161
25. Roy K (2007) On some aspects of validation of predictive quantitative structure activity relationship models. Expert Opin Drug Dis 2:1567–1577
26. Ojha PK, Mitra I, Das R, Roy K (2011) Further exploring rm2 metrics for validation of QSPR models. Chemom Intell Lab Syst 107:194–205
27. Roy K, Mitra I, Kar S, Ojha PK, Das RN, Kabir H (2012) Comparative studies on some metrics for external validation of QSPR models. J Chem Inf Model 52:396–408
28. Ojha PK, Roy K (2011) Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chemometr Intell Lab 109:146–161
29. Roy K, Das RN, Ambure P, Aher RB (2016) Be aware of error measures. Further studies on validation of predictive QSAR models. Chemom Intell Lab Syst 152:18–33
30. Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inform 29:476–488
31. Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694–701
32. Gadaleta D, Mangiatordi GF, Catto M, Carotti A, Nicolotti O (2016) Applicability domain for QSAR models: where theory meets reality. IJQSPR 1:45–63
33. Toropov AA, Toropova AP, Lombardo A, Roncaglioni A, Benfenati E, Gini G (2011) CORAL: building up the model for bioconcentration factor and defining it’s applicability domain. Eur J Med Chem 46:1400–1403
34. Verma RP, Hansch C (2005) An approach toward the problem of outliers in QSAR. Bioorg Med Chem 13:4597–4621